MoneyWorks4Me

Biocon - Quaterly Results

10 Aug 2023 Evaluate
The revenue zoomed 16.19% to Rs. 5132.00 millions for the quarter ended June 2023 as compared to Rs. 4417.00 millions during the corresponding quarter last year.Net Profit witnessed a 212.75% growth almost the double from Rs. 149.00 millions to Rs. 466.00  millions  of same quarter last year.Operating profit for the quarter ended June 2023 rose to 1080.00 millions as compared to 512.00 millions of corresponding quarter ended June 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 5132.00 4417.00 16.19 5132.00 4417.00 16.19 19929.00 17382.00 14.65
Other Income 360.00 486.00 -25.93 360.00 486.00 -25.93 2714.00 1872.00 44.98
PBIDT 1080.00 512.00 110.94 1080.00 512.00 110.94 2949.00 2483.00 18.77
Interest 483.00 1.00 48200.00 483.00 1.00 48200.00 696.00 4.00 17300.00
PBDT 794.00 511.00 55.38 794.00 511.00 55.38 30881.00 2479.00 1145.70
Depreciation 298.00 286.00 4.20 298.00 286.00 4.20 1169.00 1082.00 8.04
PBT 496.00 225.00 120.44 496.00 225.00 120.44 29712.00 1397.00 2026.84
TAX 30.00 76.00 -60.53 30.00 76.00 -60.53 1228.00 536.00 129.10
Deferred Tax -9.00 0.00 0.00 -9.00 0.00 0.00 0.00 0.00 0.00
PAT 466.00 149.00 212.75 466.00 149.00 212.75 28484.00 861.00 3208.25
Equity 6003.00 6003.00 0.00 6003.00 6003.00 0.00 6003.00 6003.00 0.00
PBIDTM(%) 21.04 11.59 81.55 21.04 11.59 81.55 14.80 14.28 3.59
Peers
Company Name CMP
Sun Pharma. Inds. 1784.25
Dr. Reddys Labs. 1197.35
Cipla 1335.60
Lupin 2012.00
Zydus Lifesciences 1141.00
View more..